![Martin R. Brown](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin R. Brown
Chief Executive Officer at Ambra Bioscience LLC
Profile
Martin R.
Brown is the founder of Ambra Bioscience LLC, which is founded in 2010, where he holds the title of Chief Executive Officer.
He previously worked as a Director of Information Systems at Eli Lilly & Co., Director at Equinox Center, Senior Vice President of Human Resources at Amylin Pharmaceuticals, Inc., and Media Contacts Relations, SVP-Finance & Operations at Elcelyx Therapeutics, Inc. Mr. Brown received his undergraduate degree and MBA from Drexel University.
Martin R. Brown active positions
Companies | Position | Start |
---|---|---|
Ambra Bioscience LLC
![]() Ambra Bioscience LLC BiotechnologyHealth Technology Ambra Bioscience LLC operates as a research and development biotechnology company. It offers Lovidia a dietary supplement. The company was founded by Martin Brown and William Trebasky in March 2010 and is headquartered in San Diego, CA. | Chief Executive Officer | 01/01/2010 |
Former positions of Martin R. Brown
Companies | Position | End |
---|---|---|
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Amylin Pharmaceuticals, Inc.
![]() Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Human Resources Officer | - |
Equinox Center | Director/Board Member | - |
Elcelyx Therapeutics, Inc.
![]() Elcelyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elcelyx Therapeutics, Inc. develops novel therapeutics based on gut sensory modulation. Its product NewMet is being developed for use by type 2 diabetes patients who have difficulty tolerating generic metformin or are contraindicated for its use. The firm also provides dietary supplements for weight management. The company was founded by Alain D. Baron in 2010 and is headquartered in San Diego, CA. | Director of Finance/CFO | - |
Training of Martin R. Brown
Drexel University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
Private companies | 4 |
---|---|
Elcelyx Therapeutics, Inc.
![]() Elcelyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elcelyx Therapeutics, Inc. develops novel therapeutics based on gut sensory modulation. Its product NewMet is being developed for use by type 2 diabetes patients who have difficulty tolerating generic metformin or are contraindicated for its use. The firm also provides dietary supplements for weight management. The company was founded by Alain D. Baron in 2010 and is headquartered in San Diego, CA. | Health Technology |
Amylin Pharmaceuticals, Inc.
![]() Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Equinox Center | |
Ambra Bioscience LLC
![]() Ambra Bioscience LLC BiotechnologyHealth Technology Ambra Bioscience LLC operates as a research and development biotechnology company. It offers Lovidia a dietary supplement. The company was founded by Martin Brown and William Trebasky in March 2010 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Martin R. Brown